Walker C, Kägi M K, Ingold P, Braun P, Blaser K, Bruijnzeel-Koomen C A, Wüthrich B
Swiss Institute of Allergy and Asthma Research (SIAF), Davos.
Clin Exp Allergy. 1993 Feb;23(2):145-53. doi: 10.1111/j.1365-2222.1993.tb00310.x.
In the first part of this study peripheral blood lymphocyte subpopulations, their activation state and various serum parameters were measured in extrinsic and intrinsic atopic dermatitis (AD) patients compared to normal individuals. Beside the characteristic eosinophilia, significantly increased numbers of CD4+ T cells with increased expression of IL-2 receptors (IL-2R) and HLA-DR were noted in the AD patients. In addition, extrinsic AD patients showed increased numbers of CD23+ B cells and decreased numbers of CD16+ natural killer cells. Moreover, increased serum levels of eosinophil cationic protein (ECP) and soluble IL-2R as well as soluble factors that prolong survival of eosinophils in vitro could be demonstrated. In the second section of this study we determine how these blood immunological parameters relate to the clinical severity of the skin lesions of AD, by weekly analysis of 12 AD patients attending a high altitude clinic for 3 to 6 weeks. The patients were divided into two groups on the basis of treatment with topical steroids, but during the observation period a significant improvement in clinical status was observed in all AD patients independent of topical steroid therapy. A progressive decrease in eosinophil and activated T cell numbers, soluble IL-2R levels and serum eosinophil survival prolonging activity could be demonstrated, which closely correlated with the clinical severity of the AD.
在本研究的第一部分,对特应性皮炎(AD)的外源性和内源性患者与正常个体相比,检测了外周血淋巴细胞亚群、它们的活化状态以及各种血清参数。除了特征性嗜酸性粒细胞增多外,AD患者中还发现CD4 + T细胞数量显著增加,白细胞介素-2受体(IL-2R)和人类白细胞抗原-DR(HLA-DR)的表达也增加。此外,外源性AD患者的CD23 + B细胞数量增加,而CD16 +自然杀伤细胞数量减少。而且,可以证明血清嗜酸性粒细胞阳离子蛋白(ECP)和可溶性IL-2R水平升高,以及体外延长嗜酸性粒细胞存活的可溶性因子增加。在本研究的第二部分,我们通过对12名在高海拔诊所就诊3至6周的AD患者进行每周分析,确定这些血液免疫学参数与AD皮肤病变的临床严重程度之间的关系。患者根据局部使用类固醇进行治疗分为两组,但在观察期内,所有AD患者无论是否接受局部类固醇治疗,临床状况均有显著改善。可以证明嗜酸性粒细胞和活化T细胞数量、可溶性IL-2R水平以及血清嗜酸性粒细胞存活延长活性逐渐降低,这与AD的临床严重程度密切相关。